← FDA Drug Approvals (Drugs@FDA)
VYKAT XR
NDA · New Drug Application · Sponsor: SOLENO THERAP · Approved 2025-03-26
Drug application
- FDA Application #
NDA216665- Application type
- New Drug Application
- Brand name
- VYKAT XR
- Generic name
- DIAZOXIDE CHOLINE
- Active ingredients
- DIAZOXIDE CHOLINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SOLENO THERAP
- Manufacturer
- Soleno Therapeutics, Inc.
- First approval
- 2025-03-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown